Brief: Catalent Q2 Revenue USD 1,030 Million Vs. IBES Estimate USD 1,013 Million
09/02/2024 12:59
Feb 09 (Reuters) - Catalent Q2 adjusted EBITDA USD 124 million vs. IBES estimate USD 129.6 million
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled